Thyrocare Technologies has reported results for fourth quarter and year ended March 31, 2022.
The company has reported fall of 42.42% in its net profit at Rs 20.35 crore for the quarter under review as compared to Rs 35.34 crore for the same quarter in the previous year. Total income of the company decreased by 11.73% at Rs 125.03 crore for Q4FY22 as compared Rs 141.64 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 43.74% in its net profit at Rs 21.24 crore for the quarter under review as compared to Rs 37.75 crore for the same quarter in the previous year. Total income of the company decreased by 11.81% at Rs 132.71 crore for Q4FY22 as compared Rs 150.48 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a rise of 26.95% in its net profit at Rs 152.05 crore as compared to Rs 119.77 crore for the previous year. Total income of the company increased by 16.93% at Rs 568.93 crore for year under review as compared to Rs 486.55 crore for year ended March 31, 2021.
For the year ended March 31, 2022, on the consolidated basis, the company has reported a rise of 55.70% in its net profit at Rs 176.14 crore as compared to Rs 113.13 crore for the previous year. Total income of the company increased by 21.90% at Rs 618.11 crore for year under review as compared to Rs 507.05 crore for year ended March 31, 2021.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7000.00 |
Max Healthcare Inst | 1008.35 |
Narayana Hrudayalay | 1265.30 |
Aster DM Healthcare | 442.70 |
Global Health | 1105.25 |
View more.. |